Barclays’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$882K Buy
683,435
+211,184
+45% +$349K ﹤0.01% 2827
2025
Q4
$1.04M Buy
472,251
+132,569
+39% +$249K ﹤0.01% 3401
2025
Q3
$550K Buy
339,682
+67,036
+25% +$140K ﹤0.01% 3749
2025
Q2
$706K Buy
272,646
+168,441
+162% +$664K ﹤0.01% 3557
2025
Q1
$701K Buy
104,205
+37,694
+57% +$267K ﹤0.01% 3312
2024
Q4
$452K Sell
66,511
-27,598
-29% -$182K ﹤0.01% 3885
2024
Q3
$780K Buy
94,109
+1,679
+2% +$12.1K ﹤0.01% 3515
2024
Q2
$586K Sell
92,430
-20,378
-18% -$157K ﹤0.01% 2949
2024
Q1
$1.05M Sell
112,808
-24,515
-18% -$287K ﹤0.01% 3087
2023
Q4
$1.75M Buy
137,323
+44,385
+48% +$462K ﹤0.01% 3024
2023
Q3
$960K Buy
92,938
+53,001
+133% +$614K ﹤0.01% 2364
2023
Q2
$524K Buy
39,937
+22,539
+130% +$276K ﹤0.01% 2726
2023
Q1
$195K Buy
17,398
+8,114
+87% +$80.1K ﹤0.01% 3804
2022
Q4
$78.3K Buy
9,284
+7,734
+499% +$73.6K ﹤0.01% 4369
2022
Q3
$26K Sell
1,550
-1,011
-39% -$18.6K ﹤0.01% 3978
2022
Q2
$37K Sell
2,561
-3,768
-60% -$77.6K ﹤0.01% 4158
2022
Q1
$157K Buy
+6,329
New +$163K ﹤0.01% 3564

Other funds holding LUNG